'Pfizer, Wyeth shareholders will benefit from merger'

Ranjit Kapadi, Senior VP, Pharma, Centrum Broking expects Pfizer and Wyeth shareholders to benefit from merger.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved